Enabling and leading commercialization and industry partnerships for a healthier world, Commercialization at UHN is the research commercialization hub based at the University Health Network in Toronto. We are the catalyst for accelerating UHN’s world-class research discoveries towards maximum patient impact globally.
Technologies discovered, developed and de-risked at UHN form the basis of products and services improving health care for patients internationally, including therapeutics, devices and diagnostics. In many cases, these represent the foundational platforms for a number of successful companies first incubated within UHN.
The ex-vivo lung perfusion keeps lungs alive outside the body prior to transplant, dramatically increasing the availability of donor lungs and doubling the lung transplant rate—and lives saved—at UHN.Learn More
Note: Latest fiscal year, unless otherwise stated; all figures in CAD
Commercial success of our most promising innovations and clinical capabilities
And retain world-class commercialization talent at UHN
UHN commercialization expertise has enabled the creation of new companies founded on UHN technologies and collaborations. These companies are now making an impact on health care around the world.
Dr, Frances Chung, a clinician investigator at UHN's Krembil Brain Institute, is the winner of the 20th annual UHN Inventor of the Year Award for her work re-imagining the standards of care for patients living with sleep apnea through the development of the STOP-Bang clinical questionnaire.View Past Winners
Proudly sponsored by Commercialization at UHN, the UHN Inventor of the Year Award recognizes an inventor or team who has made a substantial and noteworthy contribution to developing healthcare innovations with high commercialization potential.
Do you think your medical innovation is a contender?